Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by 7143309322on Jan 15, 2018 10:32pm

336 Views

Post# 27364896

RE:JP Morgan Conference

ToTheRightAndUp wrote: Sky, if it's alright, I'll post what you posted from Fred on the Prometic Facebook Page.

Email from Frederic Dumais about JP Morgan Conference

Hi Ric,

Great conference for us. We were a team from Prometic running 3 tracks of meetings per day. Almost as much pharma and business development meetings as investor, bankers and analyst meetings...More and more eye balls on the stock. Up to us to deliver as the audience keeps growing...Most common comment was, why don't you guys list on NASDAQ. Your valuation should be at least the equivalent of Fibrogen...IPF is generating a lot of interest

Regards

Fred

Frederic Dumais